Cost-effectiveness analysis of initial HIV treatment under Italian guidelines. - Wikidata - wikimedia - TriplyDB

Cost-effectiveness analysis of initial HIV treatment under Italian guidelines.

Cost-effectiveness analysis of initial HIV treatment under Italian guidelines.

http://www.wikidata.org/entity/Q35602604

about

A narrative review of cost-effectiveness analysis of people living with HIV treated with HAART: from interventions to outcomes Controlling the HIV/AIDS epidemic: current status and global challenges Lower healthcare costs associated with the use of a single-pill ARV regimen in the UK, 2004-2008.Cost-Effectiveness of Single- Versus Generic Multiple-Tablet Regimens for Treatment of HIV-1 Infection in the United States.Cost-effectiveness analysis of HIV treatment in the clinical practice of a public hospital in northern Italy.Antiretroviral therapy in HIV-infected patients: a proposal to assess the economic value of the single-tablet regimen.HIV-positive patients' perceptions of care received at a selected antiretroviral therapy clinic in Vhembe district, South Africa Triple-combination rilpivirine, emtricitabine, and tenofovir (Complera™/Eviplera™) in the treatment of HIV infection.Economic evaluation of initial antiretroviral therapy for HIV-infected patients: an update of Italian guidelines.Cost analysis of initial highly active antiretroviral therapy regimens for managing human immunodeficiency virus-infected patients according to clinical practice in a hospital setting.Early Treatment in HIV Patients: A Cost-Utility Analysis from the Italian Perspective.Cost-effectiveness analysis of tenofovir/emtricitabine and abacavir/lamivudine in combination with efavirenz or atazanavir/ritonavir for treatment-naïve adults with HIV-1 infection in the UK, based on the AIDS Clinical Trials Group 5202 clinical tri Cost effectiveness of darunavir/ritonavir combination antiretroviral therapy for treatment-naive adults with HIV-1 infection in Canada.

P2860

Q26796419-083A2798-A422-4B84-9361-43AEBDEEF32A Q30420558-5B951BEB-B093-41E0-BEDC-9396C6C19B91 Q34464437-CC1405D6-4823-4E2C-9F4C-15B7578206CC Q35903617-79D86553-A4BE-40C2-BEC0-C7F8B695E7DA Q36251587-5F385D94-D9B0-41FA-A6CB-E9BE41E290D9 Q36617684-FEA78467-937A-4D8D-865C-3DAC554BE07F Q36952943-6D0CAED9-3E52-4D76-B99F-4AEED9E3A49A Q36958229-EAAEE258-4756-4A7D-BC1E-9BD495F29D0F Q37225380-6F0B8F82-7E8F-4C01-BD8F-DEB6903C4453 Q37412246-1E9C5DA2-67B8-41DB-AE9B-994A3B35BBFE Q38759954-59D615CA-F43E-4706-ADB3-1377E72A5812 Q40215329-85560DC2-E35B-4A79-B240-CAAFA081AC5A Q42213902-AC0C0F3B-DCF5-4EF0-9AD9-081453FF9CE1

P2860

Cost-effectiveness analysis of initial HIV treatment under Italian guidelines.

http://www.wikidata.org/entity/Q35602604

description

2011 nî lūn-bûn

@nan

2011年の論文

@ja

2011年論文

@yue

2011年論文

@zh-hant

2011年論文

@zh-hk

2011年論文

@zh-mo

2011年論文

@zh-tw

2011年论文

@wuu

2011年论文

@zh

2011年论文

@zh-cn

name

Cost-effectiveness analysis of initial HIV treatment under Italian guidelines.

@ast

Cost-effectiveness analysis of initial HIV treatment under Italian guidelines.

@en

type

label

Cost-effectiveness analysis of initial HIV treatment under Italian guidelines.

@ast

Cost-effectiveness analysis of initial HIV treatment under Italian guidelines.

@en

prefLabel

Cost-effectiveness analysis of initial HIV treatment under Italian guidelines.

@ast

Cost-effectiveness analysis of initial HIV treatment under Italian guidelines.

@en

P1433

Q35602604-CF8C3243-C588-4EE9-A792-5A585D8D575F

P1476

Q35602604-CC4E1AC0-17EA-43FC-BC7D-C724B18B1E0C

P2093

Q35602604-29430A09-232A-4329-B81D-B45CA8A7F78A

Q35602604-2B29F502-E691-47C3-B8FC-8CB87987BD02

Q35602604-48615CAE-7BA8-463C-ADD1-3ACF281FB475

Q35602604-7127D4C0-1A2C-4800-AA5C-633B7DFC0EE5

Q35602604-E1E40D87-BF66-424D-B762-CABCC04579F4

Q35602604-E76465D9-614B-498B-8C96-8E2A38598F7F

P2860

Q35602604-0140ACC0-C4D5-48A7-8BE9-3D03722E3A52

Q35602604-0B445261-D1C8-444B-B4F2-BFD2DDD29611

Q35602604-1A524F89-9149-432F-8ADD-5A721C10CB0A

Q35602604-1AAFA8BD-6914-4724-9AB3-74DE6D90091E

Q35602604-1D8A4970-C40B-4A6C-93D1-E648C4D03F36

Q35602604-287DB909-B06C-4948-A5F3-08236D6AF65F

Q35602604-28BCADCB-CD82-412D-941C-FB3AD7099133

Q35602604-404605A2-1409-40BA-B826-4AF49A71E96C

Q35602604-417D0028-2BE0-4618-873A-D2A152E98E82

Q35602604-43AAD4B3-958E-4A2E-AEF7-C07E93ABA355

P304

Q35602604-E2DF50E8-6126-4D40-AC8F-066934A61D7E

P31

Q35602604-D7A63050-796F-4EFE-B213-780A11F7831F

P356

Q35602604-7EEAA9AE-F7F8-419C-B2C2-288AA28C2543

P407

Q35602604-5C66ADCB-595E-4668-B936-1BFD6C18F9B8

P478

Q35602604-773A639F-5BF8-486D-BE8B-5F0E525DDFE9

P577

Q35602604-A4953CD0-B437-4BD6-B086-362C0B52413B

P698

Q35602604-66975483-D548-4A20-83A7-331251C928A1

P921

Q35602604-1CB3FC83-1FB7-4C9B-BAA5-AF8219C0EA9C

P932

Q35602604-FEF7A191-9DF3-414B-9D04-3C984B7842EF

P356

P1433

ClinicoEconomics and Outcomes Research

P1476

Cost-effectiveness analysis of initial HIV treatment under Italian guidelines.

@en

P2093

Antonio Di Biagio

http://www.w3.org/2001/XMLSchema#string

Claudio Viscoli

http://www.w3.org/2001/XMLSchema#string

Giorgio L Colombo

http://www.w3.org/2001/XMLSchema#string

Pierluigi Viale

http://www.w3.org/2001/XMLSchema#string

Sergio Di Matteo

http://www.w3.org/2001/XMLSchema#string

Vincenzo Colangeli

http://www.w3.org/2001/XMLSchema#string

P2860

The Lifetime Cost of Current Human Immunodeficiency Virus Care in the United States

Life expectancy of individuals on combination antiretroviral therapy in high-income countries: a collaborative analysis of 14 cohort studies

Decline in the AIDS and death rates in the EuroSIDA study: an observational study.

A cost-effectiveness analysis of different therapies in patients with chronic hepatitis B in Italy

Changing health environment: the challenge to demonstrate cost-effectiveness of new compounds.

British HIV Association (BHIVA) guidelines for the treatment of HIV-infected adults with antiretroviral therapy (2006).

The combined effect of modern highly active antiretroviral therapy regimens and adherence on mortality over time.

Antiretroviral therapy and management of HIV infection.

Insights into the reasons for discontinuation of the first highly active antiretroviral therapy (HAART) regimen in a cohort of antiretroviral naïve patients. I.CO.N.A. Study Group. Italian Cohort of Antiretroviral-Naïve Patients.

Adherence to protease inhibitor therapy and outcomes in patients with HIV infection

P304

197-205

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.2147/CEOR.S24130

http://www.w3.org/2001/XMLSchema#string

P407

P478

3

http://www.w3.org/2001/XMLSchema#string

P577

2011-10-31T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

22163167

http://www.w3.org/2001/XMLSchema#string

P921

P932

3234156

http://www.w3.org/2001/XMLSchema#string